Prime Medicine Total Debt Growth & History (PRME)

Prime Medicine's total debt was $116.4M for fiscal 2025.

View full Prime Medicine company overview

Prime Medicine annual total debt history

Prime Medicine annual total debt

Fiscal yearPeriod endedTotal debtChangeGrowth
20252025-12-31$116.4M$75.6M+185.40%
20242024-12-31$40.8M$27.2M+199.23%
20232023-12-31$13.6M−$15.1M−52.57%
20222022-12-31$28.7M$18.3M+176.23%
20212021-12-31$10.4M

Prime Medicine total debt trends

Between the periods ended 2021-12-31 and 2025-12-31, Prime Medicine's total debt increased from $10.4M to $116.4M, a change of $106.0M. The latest reported quarter, Q2 2026, shows $112.5M.

About the metric

What total debt means

Total debt measures a company’s reported interest-bearing borrowing obligations at a reporting-period end. It can include short-term borrowings, current maturities, long-term debt, and finance lease obligations when they are included in the company’s debt facts.

Calculation and source

SEC-reported and combined total debt

TickerStat uses a reported aggregate debt value when available. Otherwise, it combines non-overlapping current and noncurrent debt facts from SEC filings. Total liabilities are not treated as debt, and missing debt is not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Prime Medicine source filings ↗

Community posts

It’s quiet here.

No posts about PRME yet. Start the conversation.

Write the first post